Alkermes
And finally this week there is news from Alkermes who has created two new roles and is filling them with two industry veterans.
Firstly, Srdjan (Serge) Stankovic, will serve as Senior Vice President of Clinical Development and Medical Affairs, responsible for Alkermes’ Clinical Development and Medical Affairs function. Stankovic has over 20 years of R&D experience and comes most recently from the role of Senior Vice President and Head of Global Clinical Development for Teva Pharmaceuticals.
Secondly, Peter Norman has joined the company as Vice President of Government Affairs and Policy and comes from being head of the Washington, D.C. office of Eisai where he directed government affairs and policy.
“We are very pleased to welcome Serge and Pete – two proven leaders whose expertise will contribute to Alkermes’ next stage of growth,” said Richard Pops, CEO of Alkermes. “As our portfolio of new medicines expands, we are responding by strengthening our capabilities in two areas critical for our future: global clinical development and government affairs.”